title: Accessibility of ³H-secoisolariciresinol diglycoside lignan metabolites in skeletal tissue of ovariectomized rats.
abstract: Flaxseed, rich in the phytoestrogen lignan secoisolariciresinol diglycoside (SDG), provides protection against bone loss at the lumbar vertebrae primarily when combined with low-dose estrogen therapy in the ovariectomized rat model of postmenopausal osteoporosis. Whether SDG metabolites are accessible to skeletal tissue, and thus have the potential to interact with low-dose estrogen therapy to exert direct local action on bone metabolism, is unknown. The objective of this study was to determine whether metabolites of SDG are accessible to the skeleton of ovariectomized rats and to compare the distribution of SDG metabolites in skeletal tissue with that in other tissues. Rats were fed a 10% flaxseed diet and gavaged daily with tritium-labeled SDG (7.4 kBq/g of body weight) in deionized water (500 μL) (n=3) or deionized water alone (n=3) for 7 days, after which tissues were collected for liquid scintillation counting. Radioactivity was detected in similar concentrations in the lumbar vertebrae, femurs, and tibias. Compared with non-skeletal tissues, total radioactivity in the skeleton was significantly lower than in the liver, heart, kidney, thymus, and brain (P < .001). There were no significant differences in levels of radioactivity between skeletal tissue versus the spleen, lung, bladder, uterus, vagina, and mammary gland. In conclusion, SDG metabolites are accessible to skeletal tissue of ovariectomized rats. Thus, it is biologically plausible that SDG metabolites may play a direct role in the protective effects of flaxseed combined with low-dose estrogen therapy against the loss of bone mass and bone strength in the ovariectomized rat model of postmenopausal osteoporosis.
authors.affiliation: 1 Department of Nutritional Sciences, Faculty of Medicine,  University of Toronto , Toronto, Ontario,  Canada .
authors.forename: Sandra M
authors.initials: SM
authors.lastname: Sacco
authors.forename: Lilian U
authors.initials: LU
authors.lastname: Thompson
authors.forename: Bernhard
authors.initials: B
authors.lastname: Ganss
authors.forename: Wendy E
authors.initials: WE
authors.lastname: Ward
mesh_terms: D000818:Animals; D002072:Butylene Glycols / Q000494:pharmacology*; D004195:Disease Models, Animal; D005260:Female; D005269:Femur / Q000378:metabolism*; D019597:Flax / Q000737:chemistry; D017705:Lignans / Q000494:pharmacology*; D008159:Lumbar Vertebrae / Q000378:metabolism*; D010024:Osteoporosis / Q000378:metabolism* / Q000517:prevention & control; D010052:Ovariectomy; D048789:Phytoestrogens / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013977:Tibia / Q000378:metabolism*
chemical_list: D002072:Butylene Glycols; D017705:Lignans; D048789:Phytoestrogens; C060283:secoisolariciresinol